Sa1748 CLINICAL EFFECTIVENESS AND SAFETY OF FIRST-LINE...

Gastroenterology 2020 / 05 Vol. 158; Iss. 6

Sa1748 CLINICAL EFFECTIVENESS AND SAFETY OF FIRST-LINE BIOLOGIC VEDOLIZUMAB AS A MONOTHERAPY OR COMBINATION THERAPY IN ULCERATIVE COLITIS AND CROHN'S DISEASE PATIENTS: RESULTS FROM THE EVOLVE STUDY

Bressler, Brian, Yarur, Andres J., Kopylov, Uri, Bassel, Marielle, Brett, Neil R., Colby, Chris, Lopez, Claudia, Saha, Sumit, Kifnidi, Christina, Agboton, Christian, Adsul, Shashi, Demuth, Dirk, Luo,
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
158
Journal:
Gastroenterology
DOI:
10.1016/s0016-5085(20)31710-8
Date:
May, 2020
File:
PDF, 468 KB
2020
Conversion to is in progress
Conversion to is failed